Qualitative interviews to improve patient-reported outcome measures in late-onset Pompe disease: the patient perspective
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Qualitative interviews to improve patient-reported outcome measures in late-onset Pompe disease: the patient perspective ; volume:16 ; number:1 ; day:12 ; month:10 ; year:2021 ; pages:1-12 ; date:12.2021
Orphanet journal of rare diseases ; 16, Heft 1 (12.10.2021), 1-12, 12.2021
- Urheber
-
Hamed, Alaa
An Haack, Kristina
Gwaltney, Chad
Baranowski, Eileen
Stewart, Andrew
Krupnick, Robert
Tyler, Margaret
Sparks, Susan
Paty, Jean
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-021-02067-x
- URN
-
urn:nbn:de:101:1-2021122620014133588793
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hamed, Alaa
- An Haack, Kristina
- Gwaltney, Chad
- Baranowski, Eileen
- Stewart, Andrew
- Krupnick, Robert
- Tyler, Margaret
- Sparks, Susan
- Paty, Jean
- SpringerLink (Online service)
Ähnliche Objekte (12)
Use of the patient-reported outcomes measurement information system (PROMIS®) to assess late-onset Pompe disease severity
Positive association between physical outcomes and patient-reported outcomes in late-onset Pompe disease: a cross sectional study
Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease
Fatigue: an important feature of late-onset Pompe disease
Late-Onset Pompe Disease Presenting with Isolated Tongue Involvement
Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS®) physical function questionnaire in late-onset Pompe disease using PROPEL phase 3 data
Bright tongue sign in patients with late-onset Pompe disease
Walking delay as leading symptom in late-onset Pompe disease
Alglucosidase alfa: 5 years of experience in late-onset Pompe disease
Analysis of voice quality in patients with late-onset Pompe disease
Forced vital capacity and cross-domain late-onset Pompe disease outcomes: an individual patient-level data meta-analysis
Abnormal tongue features as a clinical clue for late-onset Pompe's disease
Use of the patient-reported outcomes measurement information system (PROMIS®) to assess late-onset Pompe disease severity
Positive association between physical outcomes and patient-reported outcomes in late-onset Pompe disease: a cross sectional study
Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease
Fatigue: an important feature of late-onset Pompe disease
Late-Onset Pompe Disease Presenting with Isolated Tongue Involvement
Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS®) physical function questionnaire in late-onset Pompe disease using PROPEL phase 3 data
Bright tongue sign in patients with late-onset Pompe disease
Walking delay as leading symptom in late-onset Pompe disease
Alglucosidase alfa: 5 years of experience in late-onset Pompe disease
Analysis of voice quality in patients with late-onset Pompe disease
Forced vital capacity and cross-domain late-onset Pompe disease outcomes: an individual patient-level data meta-analysis
Abnormal tongue features as a clinical clue for late-onset Pompe's disease
Use of the patient-reported outcomes measurement information system (PROMIS®) to assess late-onset Pompe disease severity
Positive association between physical outcomes and patient-reported outcomes in late-onset Pompe disease: a cross sectional study
Switching treatment to cipaglucosidase alfa plus miglustat positively affects patient-reported outcome measures in patients with late-onset Pompe disease
Fatigue: an important feature of late-onset Pompe disease
Late-Onset Pompe Disease Presenting with Isolated Tongue Involvement
Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS®) physical function questionnaire in late-onset Pompe disease using PROPEL phase 3 data
Bright tongue sign in patients with late-onset Pompe disease
Walking delay as leading symptom in late-onset Pompe disease
Alglucosidase alfa: 5 years of experience in late-onset Pompe disease
Analysis of voice quality in patients with late-onset Pompe disease
Forced vital capacity and cross-domain late-onset Pompe disease outcomes: an individual patient-level data meta-analysis